ZA753086B - Acyl derivatives - Google Patents

Acyl derivatives

Info

Publication number
ZA753086B
ZA753086B ZA00753086A ZA753086A ZA753086B ZA 753086 B ZA753086 B ZA 753086B ZA 00753086 A ZA00753086 A ZA 00753086A ZA 753086 A ZA753086 A ZA 753086A ZA 753086 B ZA753086 B ZA 753086B
Authority
ZA
South Africa
Prior art keywords
acyl derivatives
acyl
derivatives
Prior art date
Application number
ZA00753086A
Other languages
English (en)
Inventor
R Reiner
M Montavon
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA753086B publication Critical patent/ZA753086B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00753086A 1974-06-21 1975-05-13 Acyl derivatives ZA753086B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (1)

Publication Number Publication Date
ZA753086B true ZA753086B (en) 1976-04-28

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00753086A ZA753086B (en) 1974-06-21 1975-05-13 Acyl derivatives

Country Status (25)

Country Link
JP (1) JPS625917B2 (fr)
AT (1) AT337897B (fr)
AU (1) AU498387B2 (fr)
BE (1) BE830455A (fr)
BR (1) BR7503782A (fr)
CA (1) CA1111021A (fr)
CH (1) CH609989A5 (fr)
CU (1) CU34293A (fr)
DD (1) DD121113A5 (fr)
DE (1) DE2527291A1 (fr)
DK (2) DK153155C (fr)
FI (1) FI751815A (fr)
FR (1) FR2275215A1 (fr)
GB (1) GB1471804A (fr)
HU (1) HU170576B (fr)
IE (1) IE41888B1 (fr)
IL (1) IL47299A (fr)
LU (1) LU72771A1 (fr)
NL (1) NL180665C (fr)
NO (1) NO752202L (fr)
NZ (1) NZ177508A (fr)
PH (1) PH13030A (fr)
SE (1) SE431755B (fr)
SU (2) SU635873A3 (fr)
ZA (1) ZA753086B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (nl) * 1977-06-03 1978-12-05 Hoffmann La Roche Werkwijze voor het bereiden van acylderivaten.
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
WO2002086143A2 (fr) * 2001-04-19 2002-10-31 Bioferma Murcia, S.A. Procede relatif a l'elaboration de derives de cephalosporine
EP2250156B1 (fr) 2008-03-05 2015-05-06 Merck Patent GmbH Dérivés de pyrazinone comme stimulateurs de la sécrétion d'insuline, leurs procédés d'obtention et leur utilisation pour le traitement du diabète

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
JPS5113793A (fr) 1976-02-03
GB1471804A (en) 1977-04-27
DK453687A (da) 1987-08-28
DK271975A (da) 1975-12-22
DE2527291A1 (de) 1976-01-08
CH609989A5 (en) 1979-03-30
IE41888B1 (en) 1980-04-23
HU170576B (fr) 1977-07-28
CA1111021A (fr) 1981-10-20
LU72771A1 (fr) 1977-03-04
DD121113A5 (fr) 1976-07-12
SE431755B (sv) 1984-02-27
IE41888L (en) 1975-12-21
DK453687D0 (da) 1987-08-28
DK155329B (da) 1989-03-28
ATA476975A (de) 1976-11-15
AU8191275A (en) 1976-12-09
NO752202L (fr) 1975-12-23
DK155329C (da) 1989-08-07
DK153155C (da) 1988-10-31
BE830455A (fr) 1975-12-22
JPS625917B2 (fr) 1987-02-07
SU589921A3 (ru) 1978-01-25
AU498387B2 (en) 1979-03-08
FR2275215A1 (fr) 1976-01-16
BR7503782A (pt) 1976-07-06
AT337897B (de) 1977-07-25
IL47299A (en) 1979-01-31
DE2527291C2 (fr) 1988-01-14
DK153155B (da) 1988-06-20
PH13030A (en) 1979-11-15
NL180665C (nl) 1987-04-01
FI751815A (fr) 1975-12-22
IL47299A0 (en) 1976-10-31
NL7507390A (nl) 1975-12-23
SE7506908L (sv) 1975-12-22
CU34293A (es) 1979-01-16
NL180665B (nl) 1986-11-03
SU635873A3 (ru) 1978-11-30
FR2275215B1 (fr) 1980-05-16
NZ177508A (en) 1978-04-03

Similar Documents

Publication Publication Date Title
PH11652A (en) Arloxphenylpropylamines derivatives
IL48592A0 (en) Novel 1-substituted-4-benzylpiperidine derivatives
IL48593A0 (en) Novel 1-substituted-4-benzylidenepiperidine derivatives
GB1488062A (en) Derivatives of 2-phenyl-benzofurane
ZA753968B (en) Novel benzimidazolinone derivatives
IL46341A0 (en) Alpha-aryl-4-substituted piperidinoalkanol derivatives
GB1519811A (en) Thienothaiazine derivatives
PH12312A (en) Thienothiazine derivatives
ZA757828B (en) 2-methoxy-benzamide derivatives
AU1038176A (en) 4-arylpiperidine derivatives
PH13481A (en) Rifanycin derivative
GB1484049A (en) 3-alkoxy-pyrazine-2-carboxamide derivatives
AU7921975A (en) Hexahydro-alpha-carboline derivatives
GB1521320A (en) Quinolisidine derivatives
ZA753315B (en) Oxacyclohexane derivatives
ZA751899B (en) Benzo-bicyclononene derivatives
ZA753086B (en) Acyl derivatives
ZA755543B (en) Thiomethylcephem derivatives
IL48409A0 (en) Phenyl-pyridylamine derivatives
ZA753299B (en) Amidino-hydrazone derivatives
AU8332175A (en) New hydroxyphenyl-butazone derivatives
GB1519646A (en) Derivatives of eburnamenine
GB1486646A (en) Thieno-pyridine derivatives
JPS51115457A (en) 166methyll9 alphaa halosteroid derivatives
AU8273475A (en) Isoquinoline derivatives